A Comprehensive Analysis of the Comparative Efficacy of Multimodal Diarrhea Therapies in the Paediatric Population
1 other identifier
interventional
100
0 countries
N/A
Brief Summary
The objective of this research is to assess the mean time of resolution of diarrhea in pediatric patients receiving different intervention combinations for the management of acute diarrhea. Specifically, the study aims to compare the effectiveness of four intervention groups: Group 1 receiving zinc and probiotic supplementation, Group 2 receiving zinc, probiotic, and prebiotics. Group 3 receiving zinc, probiotics, and anti-secretory agents, and Group 4 receiving zinc, probiotic, anti-secretory agents, and adsorbents. The primary outcome measure will be the mean time from the initiation of treatment to the resolution of diarrhea symptoms. This objective seeks to provide evidence-based insights into the optimal management strategies for childhood diarrhea and inform clinical practice guidelines.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for early_phase_1
Started Sep 2024
Shorter than P25 for early_phase_1
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 5, 2024
CompletedStudy Start
First participant enrolled
September 15, 2024
CompletedFirst Posted
Study publicly available on registry
September 19, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 15, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2024
CompletedSeptember 19, 2024
September 1, 2024
3 months
September 5, 2024
September 5, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
resolution of diarrhea
mean time of resolution of diarrhea in different intervention groups
3 months
Study Arms (2)
Intervention Group
ACTIVE COMPARATOR: Group 1 receiving zinc and probiotic supplementation, Group 2 receiving zinc, probiotic, and prebiotics. Group 3 receiving zinc, probiotics, and anti-secretory agents, and Group 4 receiving zinc, probiotic, anti-secretory agents, and adsorbents.
Duration of diarrhea
ACTIVE COMPARATORThis will showcase the duration of diarrhea that the pediatric population had before receiving treatment.
Interventions
. The primary outcome measure will be the mean time from the initiation of treatment to the resolution of diarrhea symptoms. This objective seeks to provide evidence-based insights into the optimal management strategies for childhood diarrhea and inform clinical practice guidelines.
Eligibility Criteria
You may qualify if:
- Pediatric patients, both male and female, aged 6 months to 5 years presenting with acute diarrhea at CMH Multan.
- Patients or caregivers willing to provide informed consent for participation in the study.
You may not qualify if:
- Pediatric Patients with chronic diarrhea or underlying gastrointestinal disorders.
- Pediatric Patients with severe dehydration requiring immediate medical intervention.
- Pediatric Patients with a history of allergy or intolerance to any of the study interventions.
- Pediatric Patients with severe comorbidities or immunocompromised status.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Combined Military Hospital Multanlead
- Saglik Bilimleri Universitesicollaborator
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Muhammad F Shafiq
CMH Multan
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- early phase 1
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- CARE PROVIDER
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
September 5, 2024
First Posted
September 19, 2024
Study Start
September 15, 2024
Primary Completion
December 15, 2024
Study Completion
December 30, 2024
Last Updated
September 19, 2024
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will not share